MILNE GEORGE M JR 4
4 · Amylyx Pharmaceuticals, Inc. · Filed Mar 20, 2023
Insider Transaction Report
Form 4
MILNE GEORGE M JR
Director
Transactions
- Sale
Common Stock
2023-03-16$32.45/sh−1,916$62,172→ 862,021 total - Sale
Common Stock
2023-03-16$31.86/sh−33,084$1,053,901→ 863,937 total
Footnotes (3)
- [F1]These sales were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2022.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.30 to $32.29. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.30 to $32.93. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.